Skip to main content

Table 1 Basic characteristics among patients and controls

From: The role of chemoprevention by selective cyclooxygenase-2 inhibitors in colorectal cancer patients - a population-based study

  

Cancer patients

Controls

Variable

Item

n

%

na

%a

p-value

total

 

21460

 

79331

  

sex

      
 

male

12882

60.0

47621

60.0

 
 

female

8578

40.0

31710

40.0

 

age group

      
 

18-64 years old

9072

42.3

33536

42.3

 
 

65-100 years old

12388

57.7

45795

57.7

 

income category

      
 

not working

6958

32.4

23361

29.4

<.001

 

monthly income<= NT$20000

11019

51.3

45805

57.7

 
 

monthly income> NT$20000

3483

16.2

10165

12.8

 

comorbidity in 5 years before index date

      
 

Myocardial infarction

486

2.3

1784

2.2

0.888

 

Congestive heart failure

1864

8.7

5917

7.5

<.001

 

Peripheral vascular disease

609

2.8

2315

2.9

0.534

 

Cerebrovascular disease

3724

17.4

13514

17.0

0.273

 

Dementia

655

3.1

2825

3.6

<.001

 

Chronic pulmonary disease

7002

32.6

25707

32.4

0.534

 

Rheumatologic disease

692

3.2

2552

3.2

0.957

 

Peptic ulcer disease

7974

37.2

21875

27.6

<.001

 

Mild liver disease

4092

19.1

12302

15.5

<.001

 

Diabetes

4853

22.6

15049

19.0

<.001

 

Diabetes with chronic complications

1462

6.8

4589

5.8

<.001

 

Hemiplegia or paraplegia

416

1.9

1609

2.0

0.408

 

Renal disease

1833

8.5

5734

7.2

<.001

 

Moderate or severe liver disease

94

0.4

298

0.4

0.191

selective COX-2 inhibitors

      
 

No

18872

87.9

69896

88.1

0.504

 

Yes

2588

12.1

9435

11.9

 
 

Average (±sd) DDD

78.0 (±151.1)

85.5 (±231.7)

0.014b

tNSAID

      
 

No

2014

9.4

8517

10.7

<.001

 

Yes

19446

90.6

70814

89.3

 
 

Average (±sd) DDD

87.2 (±145.8)

94.5 (±170.0)

0.001b

preferential COX-2 inhibitors

      
 

No

15681

73.1

57451

72.4

0.058

 

Yes

5779

26.9

21880

27.6

 
 

Average (±sd) DDD

61.6 (±121.9)

62.2 (144.6)

0.278b

  1. a: weighted according to the matched sizes of cases.
  2. b: Two-sample t-tests were conducted at the natural logarithm of average DDD.
  3. DDD: define daily dose; NT: new taiwan dollar; sd: standard deviation; tNSAID: traditional NSAID.